- Home
- BBIO vs BTX Comparison
BBIO vs BTX Comparison
Compare BBIO & BTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBIO
- BTX
- Stock Information
- Founded
- BBIO 2015
- BTX N/A
- Country
- BBIO United States
- BTX United States
- Employees
- BBIO N/A
- BTX N/A
- Industry
- BBIO Biotechnology: Pharmaceutical Preparations
- BTX
- Sector
- BBIO Health Care
- BTX
- Exchange
- BBIO Nasdaq
- BTX Nasdaq
- Market Cap
- BBIO 8.0B
- BTX 1.5B
- IPO Year
- BBIO 2019
- BTX N/A
- Fundamental
- Price
- BBIO $46.47
- BTX $7.10
- Analyst Decision
- BBIO Strong Buy
- BTX
- Analyst Count
- BBIO 14
- BTX 0
- Target Price
- BBIO $60.21
- BTX N/A
- AVG Volume (30 Days)
- BBIO 3.3M
- BTX 774.3K
- Earning Date
- BBIO 07-31-2025
- BTX 08-15-2025
- Dividend Yield
- BBIO N/A
- BTX 14.56%
- EPS Growth
- BBIO N/A
- BTX N/A
- EPS
- BBIO N/A
- BTX N/A
- Revenue
- BBIO $127,415,000.00
- BTX N/A
- Revenue This Year
- BBIO $107.34
- BTX N/A
- Revenue Next Year
- BBIO $49.48
- BTX N/A
- P/E Ratio
- BBIO N/A
- BTX N/A
- Revenue Growth
- BBIO N/A
- BTX N/A
- 52 Week Low
- BBIO $21.72
- BTX $5.10
- 52 Week High
- BBIO $46.80
- BTX $8.31
- Technical
- Relative Strength Index (RSI)
- BBIO 71.64
- BTX N/A
- Support Level
- BBIO $41.80
- BTX N/A
- Resistance Level
- BBIO $46.80
- BTX N/A
- Average True Range (ATR)
- BBIO 1.44
- BTX 0.00
- MACD
- BBIO 0.09
- BTX 0.00
- Stochastic Oscillator
- BBIO 94.00
- BTX 0.00
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About BTX BlackRock Technology and Private Equity Term Trust Common Shares of Beneficial Interest
BlackRock Technology and Private Equity Term Trust objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust will invest in equity securities issued by mid - and small capitalization companies that the Trust's adviser believes have above-average earnings growth potential.